Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Abkevich

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancerBryan T J Hennessy, Kirsten M Timms, Mark S Carey, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
American Journal of Human Genetics|April 17, 2002
A major predisposition locus for severe obesity, at 4p15-p14Steven Stone, Victor Abkevich, Steven C Hunt, et al.
American Journal of Human Genetics|May 13, 2008
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritisAna M Valdes, John Loughlin, Kirsten M Timms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Melinda L Telli, Kristin C Jensen, Shaveta Vinayak, et al.
Breast Cancer Research and Treatment|May 27, 2015
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)Virginia G Kaklamani, Jacqueline S Jeruss, Elisha Hughes, et al.
JCO Precision Oncology|November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry CompositionElisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
American Journal of Human Genetics|November 8, 2003
Predisposition locus for major depression at chromosome 12q22-12q23.2Victor Abkevich, Nicola J Camp, Charles H Hensel, et al.
Obesity (Silver Spring, Md.)|September 25, 2007
Meta-analysis of genome-wide linkage studies in BMI and obesityCatherine L Saunders, Benedetta D Chiodini, Pak Sham, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancerBryan T J Hennessy, Kirsten M Timms, Mark S Carey, et al.
Human Molecular Genetics|March 28, 2008
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility geneFrancesca Capon, Marie-José Bijlmakers, Natalie Wolf, et al.
American Journal of Human Genetics|April 17, 2002
A major predisposition locus for severe obesity, at 4p15-p14Steven Stone, Victor Abkevich, Steven C Hunt, et al.
American Journal of Human Genetics|May 13, 2008
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritisAna M Valdes, John Loughlin, Kirsten M Timms, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Melinda L Telli, Kristin C Jensen, Shaveta Vinayak, et al.
Breast Cancer Research and Treatment|May 27, 2015
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)Virginia G Kaklamani, Jacqueline S Jeruss, Elisha Hughes, et al.
JCO Precision Oncology|November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry CompositionElisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
American Journal of Human Genetics|November 8, 2003
Predisposition locus for major depression at chromosome 12q22-12q23.2Victor Abkevich, Nicola J Camp, Charles H Hensel, et al.
Obesity (Silver Spring, Md.)|September 25, 2007
Meta-analysis of genome-wide linkage studies in BMI and obesityCatherine L Saunders, Benedetta D Chiodini, Pak Sham, et al.
Pageof 2